Legacy Financial Advisors, Inc.

Position in EXEL — Exelixis, Inc.

CIK 1730810 COVINGTON, KY

Position in EXEL

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$256,924

+$34,400 QoQ

Shares Held

4,722

-7.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#546

of 751 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legacy Financial Advisors, Inc. holds $3,774,599 across 5 Biotechnology names. EXEL ranks #5 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,139	$1,559,235
2	REGN	Regeneron Pharmaceuticals, Inc.	1,438	$896,650
3	IBRX	ImmunityBio, Inc.	81,230	$711,168
4	INCY	Incyte Corp	3,093	$350,622
5	EXEL	Exelixis, Inc. This page	4,722	$256,924

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$256,924	4,722	-7.0%	Shares	Sole	2026-08-05
2025-12-31	$222,524	5,077	—	Shares	Sole	2026-02-04
No filing history on record for this holder in this stock.